Measurement of plasma and urinary adrenomedullin in patients with IgA nephropathy

被引:25
作者
Kubo, A
Iwano, M
Minamino, N
Sato, H
Nishino, T
Hirata, E
Akai, Y
Shiiki, H
Kitamura, K
Kangawa, K
Matsuo, H
Dohi, K
机构
[1] Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 565, Japan
[2] Nara Med Univ, Dept Internal Med 1, Nara, Japan
[3] Miyazaki Med Coll, Dept Internal Med 1, Miyazaki 88916, Japan
关键词
adrenomedullin; plasma; urine; blood urea nitrogen; IgA nephropathy; potassium; serum creatinine; sodium;
D O I
10.1159/000044966
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In this study, we measured plasma and urinary adrenomedullin (AM) concentrations in 47 patients with IgA nephropathy. Controls were 39 healthy volunteers. Plasma and urinary AM values were measured by specific radioimmunoassay. The plasma AM concentrations were higher, and the urinary AM levels were lower in patients with IgA nephropathy than in healthy volunteers. Plasma AM concentrations showed a positive correlation with serum creatinine and blood urea nitrogen, whereas urinary AM levels correlated negatively with serum creatinine and blood urea nitrogen. The plasma AM concentrations showed a positive correlation with fractional excretions of sodium and potassium. Renal biopsy specimens of patients without renal failure were scored for activity (percentage of glomeruli demonstrating cellular crescent formation, degree of mesangial proliferation and interstitial infiltration; total score = 9). Urinary AM levels were shown to be lower in the group with a high activity (score 3-9) as compared with the group with a low activity (score 0-2) based on renal biopsy. Thus, urinary levels of AM are affected by the degree of the activity in IgA nephropathy, and AM may participate in the pathophysiology of IgA nephropathy.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 29 条
[1]   TREATMENT OF SEVERE IGA NEPHROPATHY IN CHILDREN [J].
ANDREOLI, SP ;
BERGSTEIN, JM .
PEDIATRIC NEPHROLOGY, 1989, 3 (03) :248-253
[2]   ADRENOMEDULLIN SUPPRESSES MITOGENESIS IN RAT MESANGIAL CELLS VIA CAMP PATHWAY [J].
CHINI, EN ;
CHOI, E ;
GRANDE, JP ;
BURNETT, JC ;
DOUSA, TP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (03) :868-873
[3]  
CONTE G, 1997, KIDNEY INT S, V59, P28
[4]  
EBRA T, 1994, EUR J PHARMACOL, V263, P69
[5]   EFFECTS OF CALCITONIN-GENE-RELATED PEPTIDE RECEPTOR ANTAGONISTS ON RENAL ACTIONS OF ADRENOMEDULLIN [J].
ELHAWARY, AM ;
POON, J ;
PANG, CCY .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) :1133-1140
[6]  
EMANCIPATOR SN, 1983, PATHOLOGY KIDNEY, V1, P389
[7]  
ETO T, 1996, KIDNEY INT S55, V49, P148
[8]   IGA NEPHROPATHY [J].
GALLA, JH .
KIDNEY INTERNATIONAL, 1995, 47 (02) :377-387
[9]   PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
HASEGAWA, K ;
MATSUSHITA, Y ;
INOUE, T ;
MORII, H ;
ISHIBASHI, M ;
YAMAJI, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :819-822
[10]   MECHANISMS OF ADRENOMEDULLIN-INDUCED VASODILATION IN THE RAT-KIDNEY [J].
HIRATA, Y ;
HAYAKAWA, H ;
SUZUKI, Y ;
SUZUKI, E ;
IKENOUCHI, H ;
KOHMOTO, O ;
KIMURA, K ;
KITAMURA, K ;
ETO, T ;
KANGAWA, K ;
MATSUO, H ;
OMATA, M .
HYPERTENSION, 1995, 25 (04) :790-795